checkAd

    MYLAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL  680  0 Kommentare KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mylan N.V. - MYL

    NEW ORLEANS, LA--(Marketwired - October 21, 2016) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 12, 2016 to file lead plaintiff applications in a securities class action lawsuit against Mylan N.V. (NASDAQ: MYL), if they purchased the Company's securities between February 21, 2012 and October 7, 2016, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.

    What You May Do

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Barrick Gold Corporation!
    Long
    15,06€
    Basispreis
    1,87
    Ask
    × 7,41
    Hebel
    Short
    18,97€
    Basispreis
    1,89
    Ask
    × 7,33
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    If you purchased shares of Mylan and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by December 12, 2016.

    About the Lawsuit

    Mylan and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

    On September 2, 2016, it was reported that the Centers for Medicare & Medicaid Services had "informed Mylan that it incorrectly classified EpiPen as a generic under the Medicaid rebate program, which caused financial consequences for federal and state governments by reducing the amount of quarterly rebates Mylan owed for its product."

    Then, on October 7, 2016, Mylan announced that it had reached a $465 million settlement with the Department of Justice regarding the classification of EpiPen and that it had received a request from the SEC for documents related to the Medicaid rebate program.

    About Kahn Swick & Foti, LLC

    KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

    To learn more about KSF, you may visit www.ksfcounsel.com.

    Lesen Sie auch

    Contact:
    Kahn Swick & Foti, LLC
    Lewis Kahn
    Managing Partner
    lewis.kahn@ksfcounsel.com
    1-877-515-1850
    206 Covington St.
    Madisonville, LA 70447



    Diskutieren Sie über die enthaltenen Werte



    Verfasst von Marketwired
    MYLAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mylan N.V. - MYL NEW ORLEANS, LA--(Marketwired - October 21, 2016) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 12, 2016 to file lead plaintiff …

    Schreibe Deinen Kommentar

    Disclaimer